Profile data is unavailable for this security.
About the company
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
- Revenue in JPY (TTM)14.92bn
- Net income in JPY3.69bn
- Incorporated2016
- Employees316.00
- LocationTauns Laboratories Inc761-1, KamishimaIZUNOKUNI-SHI 410-2325JapanJPN
- Phone+81 558768181
- Fax+81 558760022
- Websitehttps://www.tauns.co.jp/
More ▼
Mergers & acquisitions
| Acquired company | 197A:TYO since announced | Transaction value |
|---|---|---|
| Clairvo Technologies Inc | 5.67% | 486.00k |
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mizuho Medy Co Ltd | 11.26bn | 3.43bn | 33.85bn | 187.00 | 9.88 | 1.81 | 9.17 | 3.01 | 179.80 | 179.80 | 591.12 | 980.86 | 0.5225 | 1.55 | 2.09 | -- | 15.90 | 27.74 | 17.96 | 33.06 | 69.44 | 74.51 | 30.43 | 36.69 | 6.46 | -- | -- | -- | -1.48 | 21.77 | -9.22 | 62.07 | 23.87 | -- |
| Rion Co Ltd | 27.94bn | 2.98bn | 35.47bn | 1.01k | 11.89 | 1.07 | 8.15 | 1.27 | 241.73 | 241.73 | 2,267.25 | 2,682.20 | 0.7175 | 1.67 | 3.89 | 27,692,170.00 | 7.65 | 6.57 | 8.72 | 7.62 | 49.53 | 50.11 | 10.66 | 9.27 | 3.55 | -- | 0.00 | 28.39 | 8.36 | 5.37 | 7.82 | 9.95 | 20.04 | 8.61 |
| Nippon Care Supply Co., Ltd. | 34.10bn | 2.17bn | 39.38bn | 1.45k | 17.40 | 2.10 | 4.22 | 1.15 | 139.36 | 139.36 | 2,194.67 | 1,155.76 | 1.26 | 101.80 | 30.35 | 23,453,350.00 | 8.00 | 7.37 | 11.52 | 9.80 | 36.45 | 36.77 | 6.35 | 6.34 | 0.7615 | -- | 0.0913 | 59.80 | 11.94 | 10.88 | 13.57 | 3.70 | 13.33 | 8.76 |
| Cyberdyne Inc | 4.11bn | -3.00m | 41.10bn | 211.00 | -- | 1.59 | 65.13 | 10.00 | -0.0142 | -0.0142 | 19.46 | 188.52 | 0.0833 | 1.60 | 7.70 | 19,469,190.00 | -0.1034 | -1.36 | -0.1056 | -1.38 | 61.08 | 57.96 | -1.24 | -20.80 | 13.94 | -- | 0.0108 | -- | 0.689 | 19.59 | 60.91 | -- | -5.51 | -- |
| Win-Partners Co Ltd | 87.25bn | 2.14bn | 43.71bn | 630.00 | 18.89 | 1.73 | 18.12 | 0.501 | 75.85 | 75.85 | 3,098.48 | 830.26 | 1.83 | 21.98 | 4.45 | 138,488,200.00 | 4.49 | 4.29 | 8.52 | 7.92 | 11.98 | 12.40 | 2.45 | 2.59 | 1.62 | -- | 0.00 | 68.00 | 5.64 | 4.75 | 9.98 | 1.52 | 33.83 | 9.52 |
| France Bed Holdings Co Ltd | 61.19bn | 2.72bn | 46.35bn | 1.81k | 18.62 | 1.13 | 5.82 | 0.7575 | 71.65 | 71.65 | 1,627.81 | 1,177.55 | 0.9017 | 2.94 | 6.06 | 33,769,870.00 | 4.01 | 4.19 | 5.05 | 5.65 | 55.00 | 53.37 | 4.45 | 4.78 | 1.95 | 1,504.33 | 0.2441 | 46.93 | 2.38 | 2.93 | -6.00 | 14.15 | -2.50 | 7.39 |
| Japan Eyewear Holdings Co Ltd | 17.99bn | 4.22bn | 47.64bn | 580.00 | 11.43 | 2.80 | 7.95 | 2.65 | 172.64 | 172.64 | 736.69 | 704.93 | 0.4741 | 1.80 | 16.56 | 31,022,410.00 | 11.13 | -- | 12.75 | -- | 79.15 | -- | 23.48 | -- | 0.7853 | 18.06 | 0.4966 | -- | 23.20 | -- | 80.15 | -- | -- | -- |
| Medikit Co Ltd | 23.68bn | 3.09bn | 47.64bn | 989.00 | 14.15 | 0.9524 | 10.47 | 2.01 | 211.98 | 211.98 | 1,621.48 | 3,149.96 | 0.4643 | 3.14 | 4.10 | 23,940,550.00 | 6.07 | 5.70 | 6.72 | 6.30 | 38.55 | 39.37 | 13.07 | 13.84 | 5.33 | -- | 0.0002 | 41.81 | 3.22 | 2.54 | -1.82 | 0.8548 | 21.57 | 12.47 |
| Nagaileben Co Ltd | 16.69bn | 2.48bn | 55.36bn | 501.00 | 22.34 | 1.43 | 20.08 | 3.32 | 80.62 | 80.62 | 544.00 | 1,263.59 | 0.3898 | 1.32 | 4.20 | 33,321,640.00 | 5.78 | 6.90 | 6.13 | 7.43 | 39.37 | 43.35 | 14.84 | 18.68 | 10.68 | -- | 0.00 | 67.12 | 3.48 | -0.097 | -8.81 | -5.82 | 16.97 | 0.00 |
| TAUNS Laboratories Inc | 14.92bn | 3.69bn | 59.48bn | 316.00 | 16.46 | 3.42 | 13.39 | 3.99 | 33.95 | 33.95 | 139.96 | 163.58 | 0.3721 | 0.9162 | 2.13 | 47,226,430.00 | 9.20 | -- | 13.12 | -- | 64.90 | -- | 24.72 | -- | 0.9488 | 31.13 | 0.56 | -- | 1.05 | -- | 9.38 | -- | -- | -- |
| Kitazato Corp | 10.98bn | 3.98bn | 61.04bn | 86.00 | 15.32 | 3.14 | 14.64 | 5.56 | 99.60 | 99.60 | 274.45 | 485.65 | 0.5723 | 1.83 | 8.92 | -- | 20.77 | -- | 21.73 | -- | 66.93 | -- | 36.29 | -- | 14.33 | -- | 0.00 | -- | 2.20 | -- | -4.63 | -- | -- | -- |
| Shofu Inc | 38.97bn | 4.25bn | 64.60bn | 1.41k | 15.17 | 1.41 | 11.92 | 1.66 | 118.98 | 118.98 | 1,092.32 | 1,279.85 | 0.7574 | 1.23 | 9.81 | 27,577,490.00 | 8.28 | 7.27 | 9.27 | 8.24 | 59.45 | 58.41 | 10.94 | 9.75 | 2.72 | -- | 0.00 | 32.99 | 10.31 | 8.19 | 18.11 | 43.72 | -3.19 | 30.39 |
| Eiken Chemical Co Ltd | 41.28bn | 3.83bn | 88.43bn | 702.00 | 22.06 | 1.93 | 13.90 | 2.14 | 116.07 | 116.07 | 1,238.23 | 1,326.89 | 0.6669 | 2.86 | 3.23 | 58,797,720.00 | 6.19 | 7.23 | 8.08 | 9.10 | 39.63 | 45.17 | 9.29 | 10.64 | 1.37 | 33.81 | 0.0642 | 40.76 | 1.22 | 2.07 | -15.41 | -8.83 | 13.89 | 12.05 |
Data as of Feb 13 2026. Currency figures normalised to Tauns Laboratories Inc's reporting currency: Japanese Yen JPY
1.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 30 Sep 2025 | 714.30k | 0.69% |
| Nomura Asset Management Co., Ltd.as of 11 Jun 2025 | 404.20k | 0.39% |
| Mellon Investments Corp.as of 06 Feb 2026 | 148.50k | 0.14% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 101.30k | 0.10% |
| Global X Japan Co., Ltd.as of 06 Feb 2026 | 100.20k | 0.10% |
| Asset Management One Co., Ltd.as of 31 Dec 2024 | 15.00k | 0.02% |
| DFA Australia Ltd.as of 30 Nov 2025 | 5.50k | 0.01% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 4.40k | 0.00% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 4.10k | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
